New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
November 21, 2014
16:34 EDTCTRPRoyal Caribbean, Ctrip.com announce joint venture through SkySea Cruises
Subscribe for More Information
12:31 EDTNFLXAmazon.com looking to launch new video streaming service, NY Post says
Subscribe for More Information
10:01 EDTMATOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:39 EDTMATMattel coverage resumed with a Neutral at Goldman
Subscribe for More Information
07:51 EDTMRKBofA/Merrill biotech analysts hold analyst/industry conference call
Subscribe for More Information
06:17 EDTCTRPCtrip.com initiated with an Overweight at HSBC
Subscribe for More Information
06:01 EDTNFLXStocks with implied volatility below IV index mean; BHI NFLX
Subscribe for More Information
November 20, 2014
14:52 EDTNFLXNetflix to discuss future of TV with top industry executives, Re/code says
Netflix is holding a summit about the future of TV next month, according to Re/code The company invited many of the leading executives from the TV and film industries to the private event, the website added. Reference Link
13:31 EDTLTMDillard's rallies after hedge fund pushes REIT option
Subscribe for More Information
07:11 EDTMRKBofA/Merrill to hold a conference
Subscribe for More Information
06:48 EDTNFLXNetflix's Kelly Merryman to join YouTube, TechCrunch reports
Subscribe for More Information
06:39 EDTNFLXStocks with implied volatility below IV index mean; GNW NFLX
Stocks with implied volatility below IV index mean; Genworth (GNW) 53, Netflix (NFLX) 31 according to iVolatility.
November 19, 2014
19:16 EDTNFLXNetflix orders fourth season of Longmire
Subscribe for More Information
14:25 EDTNFLXOptions Update; November 14, 2014
Subscribe for More Information
13:42 EDTTSNTyson Foods sees FY15 adjusted EPS $3.30-$3.40, consensus $3.40
Subscribe for More Information
13:29 EDTNFLXCharter CEO sees Comcast, Time Warner Cable deal getting done
Subscribe for More Information
11:50 EDTGDOTSenate Special Aging Committee to hold a hearing
Subscribe for More Information
09:39 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:38 EDTNFLXCCS Insight predicts Netflix to be acquired next year, FT reports
CCS Insight, a U.K.-based technology research firm, is predicting that a major internet player such as Yahoo (YHOO), Alibaba (BABA) or Google (GOOG) will buy Netflix (NFLX) next year, reported Financial Times. Reference Link
07:52 EDTMRKInforma Business Information to hold a conference
Subscribe for More Information
07:07 EDTGDOTCitigroup to hold a conference
Subscribe for More Information
06:34 EDTNFLXNielsen to begin measuring viewing of subscription video services, WSJ reports
Subscribe for More Information
06:00 EDTNFLXStocks with implied volatility below IV index mean; PCLN NFLX
Stocks with implied volatility below IV index mean; Priceline (PCLN) 22, Netflix (NFLX) 29 according to iVolatility.
November 18, 2014
17:40 EDTNFLXNetflix to launch in Australia, New Zealand in March, 2015
Subscribe for More Information
07:30 EDTTSNMorgan Stanley to hold a conference
Subscribe for More Information
06:39 EDTMRKAstraZeneca: 'Hard to comment' on whether Pfizer will come back, Reuters reports
Subscribe for More Information
05:57 EDTNFLXStocks with implied volatility below IV index mean; PCLN NFLX
Stocks with implied volatility below IV index mean; Priceline (PCLN) 22, Netflix (NFLX) 30 according to iVolatility.
November 17, 2014
11:55 EDTMRKMerck says IMPROVE-IT study met all primary, secondary endpoints
Merck announced that the investigational IMPROVE-IT study met its primary and all secondary composite efficacy endpoints. In IMPROVE-IT, patients taking the LDL-cholesterol-lowering medicine VYTORIN – which combines simvastatin with the non-statin ZETIA -- experienced significantly fewer major cardiovascular events than patients treated with simvastatin alone. The results from this 18,144-patient study of high-risk patients presenting with acute coronary syndromes were presented today during the late-breaking clinical trials session at the American Heart Association 2014 Scientific Sessions. Merck plans to submit the data from IMPROVE-IT to the U.S. Food and Drug Administration in mid-2015 to support a new indication for reduction of major cardiovascular events for VYTORIN and ZETIA. VYTORIN and ZETIA are currently indicated for use along with a healthy diet to reduce elevated LDL cholesterol in patients with hyperlipidemia. The current U.S. Prescribing Information for both products states that the effect of ezetimibe on cardiovascular morbidity and mortality, alone or incremental to statin therapy, has not been determined.
10:29 EDTTSNTyson advances after profit beats expectations
Shares of meat producer Tyson Foods (TSN) are climbing after the company reported higher than expected profits and roughly in-line revenue. The company also made optimistic comments about the outlook for its meat products. WHAT'S NEW: Tyson reported fourth quarter earnings per share, excluding some items, of 87c, versus analysts' consensus estimate of 76c. The company's Q4 revenue of $10.11B was roughly in-line with expectations. Tyson provided fiscal 2015 EPS guidance of $3.30-$3.40, versus the consensus outlook of $3.33. However, the meat producer's fiscal 2015 revenue guidance came in at $42B, compared with the consensus outlook of $42.51B. Tyson expects its chicken segment to generate a 7%-9% return on sales over the long-term, but a return on sales of more than 10% in fiscal 2015. Hillshire Brands, which was acquired by Tyson earlier this year, should generate revenue synergies of $4B in fiscal 2015, added Tyson. Meanwhile, demand for beef is "very strong," and pork margins should be good in 2015, the meat producer stated. PRICE ACTION: In late morning trading, Tyson gained 4% to $42.34. Other meat producers also advanced, with Sanderson Farms (SAFM) rising 0.5% to $84.17 and Hormel Foods (HRL) gaining 0.6% to $54.84.
09:49 EDTTSNTyson Foods says 'very optimistic' about demand in chicken segment
Subscribe for More Information
09:26 EDTTSNTyson says demand for beef 'very strong'
Subscribe for More Information
09:22 EDTTSNTyson Foods trades higher after earnings, levels to watch
Subscribe for More Information
09:22 EDTTSNOn The Fly: Pre-market Movers
Subscribe for More Information
08:34 EDTMRKMerck says IMPROVE-IT met primary endpoint
Subscribe for More Information
07:35 EDTTSNTyson Foods sees Hillshire acquisition adding $4B in revenues in FY15
The company says "We expect to realize substantial synergies from combining our Prepared Foods business with Hillshire Brands. Synergies are expected to come primarily from operational improvements, purchasing and distribution. As we execute our Prepared Foods strategy, we estimate the impact of the Hillshire Brands synergies, along with the cost savings and the production efficiencies associated with the previously announced plant closures, will positively impact our Prepared Foods segment by more than $225 million in fiscal 2015, and more than $500 million by the third full year of ownership. As we continue to integrate these businesses and deliver the first year synergies, the near-term results for fiscal 2015 are expected to be above the top end of our prior range of 6% despite a projected increase in raw material costs. However, as a result of the improvements we have made in our Prepared Foods business, our acquisition of Hillshire Brands and the significant synergies we expect to realize over the next few years, we believe the long-term profitability of this business should be between 10-12%."
07:35 EDTTSNTyson Foods sees FY15 sales $42B, consensus $42.51B
Subscribe for More Information
07:33 EDTTSNTyson Foods sees FY15 adjusted EPS $3.30-$3.40, consensus $3.33
Subscribe for More Information
07:32 EDTTSNTyson Foods reports Q4 adjusted EPS 87c, consensus 76c
Reports Q4 revenue $10.11B, consensus $10.16B.
07:16 EDTALKSMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
07:00 EDTMCKNovaBay signs distribution agreement with McKesson
NovaBay (NBY) has signed a nationwide distribution agreement with McKesson Corporation (MCK). The agreement covers NovaBay’s i-LidTM Cleanser, a prescription lid and lash hygiene product for the management of debilitating eye conditions such as blepharitis, Meibomian gland dysfunction and associated dry eye.
November 16, 2014
13:26 EDTMRKMerck: KEYTRUDA showed superiority to chemotherapy for primary endpoint of PFS
Subscribe for More Information
November 14, 2014
17:07 EDTNFLXSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
17:01 EDTNFLXIcahn Associates gives quarterly update on stakes
Subscribe for More Information
16:01 EDTNFLXOptions Update; November 14, 2014
Subscribe for More Information
14:53 EDTMRKCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
11:46 EDTMRKMerck management to meet with SunTrust
Subscribe for More Information
11:37 EDTNFLXNetflix shuts down public API today, Gigaom reports
Subscribe for More Information
07:14 EDTMCKAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
06:19 EDTNFLXStocks with implied volatility below IV index mean; PCLN NFLX
Subscribe for More Information
November 13, 2014
11:54 EDTALKSJanssen announces FDA approved sNDA for INVEGA SUSTENNA
Subscribe for More Information
10:20 EDTMATDreamWorks rallies on reports of potential takeover, Sterne Agee skeptical
Subscribe for More Information
10:01 EDTTSNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:54 EDTCTRPCtrip.com rises 3.7% to $58.81 amid rumor of Baidu interest
Subscribe for More Information
07:24 EDTGDOTSunTrust to hold a conference
Subscribe for More Information
06:44 EDTTSNTyson Foods initiated with an Outperform at RBC Capital
Target $48.
06:29 EDTMATMattel deal with DreamWorks likely not renewed with merger, says Wells Fargo
Subscribe for More Information
November 12, 2014
11:17 EDTMRKLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
09:37 EDTNFLXActive equity options trading
Active equity options trading according to Track Data: AAPL CLSN TWTR BABA NFLX TSLA AMZN CSIQ C
08:19 EDTGDOTJPMorgan to hold a conference
Subscribe for More Information
08:18 EDTNFLXNetflix CFO expects to expand as much or 'bit more' next year, Bloomberg says
Netflix CFO David Wells said the company plans a “sizable expansion” into new markets next year, projecting expansion on the order of this year or "even potentially a little bit more,” reported Bloomberg, citing Wells' comments at an RBC Capital Markets conference. Reference Link
08:13 EDTMRKBoston Biotech to hold a conference
Subscribe for More Information
06:53 EDTTSNTyson Foods volatility elevated into Q4 and outlook
Subscribe for More Information
November 11, 2014
16:01 EDTNFLX, MRKOptions Update; November 11, 2014
Subscribe for More Information
15:43 EDTMRKLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
09:37 EDTMRKActive equity options trading
Subscribe for More Information
08:10 EDTMRKMerck reports results from Phase 2 study of Grazoprevir/Elbasvir
Subscribe for More Information
November 10, 2014
16:44 EDTNFLXOn The Fly: Closing Wrap
Subscribe for More Information
15:53 EDTMCKCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
15:43 EDTDELLAmerican Petroleum Institute to hold a conference
Subscribe for More Information
15:17 EDTGDOTCFPB may require added disclosures on prepaid cards, WSJ says
The Consumer Financial Protection Bureau is expected to propose new rules later this week that will require more disclosure for prepaid debit cards and cracking down on allowing consumers to spend more money on the cards than they have, according to The Wall Street Journal, citing people familiar with the matter. The rules come as traditional financial institutions, such as JPMorgan (JPM) and American Express (AXP) have moved into the business and the industry’s biggest players don’t allow overdrafts so it is unclear whether the new rules will dent industry profits, the report said. Green Dot (GDOT) also does not permit overdrafts and Visa (V) recently excluded overdraft abilities in guidelines for its prepaid cards, the report added. Reference Link
15:07 EDTGDOTRegulators may require added disclosures on prepaid cards, DJ says
Subscribe for More Information
14:09 EDTNFLXBoehner strongly opposes net neutrality
Subscribe for More Information
13:26 EDTNFLXCable providers fall after Obama weighs in on net neutrality
Subscribe for More Information
12:24 EDTNFLXOn The Fly: Midday Wrap
Stocks on Wall Street were modestly higher at midday. The averages opened mixed, but very close to the flat line, and have continued to drift slowly higher from that point. There is little to stand in the way of the market’s drift, as the economic calendar is quiet, the earnings season is winding down, and the most closely watched geopolitical situations are currently status quo. ECONOMIC EVENTS: In the U.S., little of note was on the economic calendar. The Federal Reserve's newly introduced Labor Market Conditions Index was flat at 4 in October. The Fed started updating estimates of the LMCI every month beginning with last month. COMPANY NEWS: Shares of Netflix (NFLX) advanced about 1% after xxx President Barack Obama publicly urged the Federal Communications Commission to implement the "strongest possible rules" to protect net neutrality. In response, Verizon (VZ) said it supports the open Internet and continues to believe that the "light-touch regulatory approach in place for the past two decades has been central to the Internet’s success," adding that it believes the reclassification Obama called for would "apply 1930s-era utility regulation to the Internet" and be a "radical reversal of course" that would threaten great harm to an open Internet, competition and innovation." A number of Internet Service Providers, including Comcast (CMCSA), Time Warner Cable (TWC), Charter (CHTR) and Cablevision (CVC), moved lower after Obama weighed in on the hot-button issue. MAJOR MOVERS: Among the notable gainers was Achillion Pharmaceuticals (ACHN), which rose 22% after the company presented data from the ongoing Phase 2 study of its Hepatitis C virus treatment at the Annual Meeting of the American Association for the Study of Liver Diseases, or AASLD. Also higher was Dean Foods (DF), which rose more than 13% after the dairy products distributor’s third quarter results, as well as its fourth quarter and full year profit outlook, surpassed analysts’ consensus estimates. Among the noteworthy losers was Rayonier (RYN), which dropped 13% after management determined that there was a material weakness in the company's internal controls, restated certain previously made financial statements, and cut its dividend reflecting expectations of reduced cash available for distribution due to lower expected annual harvest levels. INDEXES: Near midday, the Dow was up 18.55, or 0.11%, to 17,592.48, the Nasdaq was up 10.77, or 0.23%, to 4,643.30, and the S&P 500 was up 4.01, or 0.2%, to 2,035.93.
12:09 EDTTSNUSDA raises 2014 meat production forecast, lowers 2015
Subscribe for More Information
09:45 EDTNFLXObama urges FCC to enact 'strongest possible rules' to protect net neutrality
Subscribe for More Information
09:43 EDTNFLXObama urges FCC to enact 'strongest possible rules' to protect net neutrality
Subscribe for More Information
09:20 EDTMRKOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTMRKGilead rises after Merck presents data on HCV combo
Subscribe for More Information
07:23 EDTNFLXRBC Capital to hold a conference
Subscribe for More Information
07:20 EDTMRKGilead overhang from Merck HCV combo removed, says Wells Fargo
Subscribe for More Information
07:19 EDTALKSCredit Suisse to hold a conference
Subscribe for More Information
05:58 EDTNFLXStocks with implied volatility below IV index mean; CHK NFLX
Subscribe for More Information
November 9, 2014
18:58 EDTMRKMerck presents interim data from C-SWIFT study
Merck announced the presentation of interim data from the C-SWIFT study exploring the potential of a candidate triple-therapy regimen consisting of the fixed-dose combination of grazoprevir/elbasvir , the company’s investigational NS3/4A protease inhibitor and NS5A inhibitor, in combination with sofosbuvir, a nucleotide inhibitor for the treatment of chronic hepatitis C virus, HCV, infection. Preliminary findings in treatment-naďve HCV genotype 1- infected non-cirrhotic patients, following six and four weeks of treatment, and patients with cirrhotic disease, following eight and six weeks of treatment, will be presented by Dr. Eric Lawitz, vice president, scientific and research development, The Texas Liver Institute, San Antonio, TX and C-SWIFT lead investigator. This poster presentation is part of a late-breaking abstract session at the 65th American Association for the Study of Liver Diseases, AASLD, Annual Meeting, also known as The Liver Meeting. “These interim data provide a compelling proof-of-concept for the potential of an eight- or six-week triple therapy course in treatment-naive patients with genotype 1 disease, including cirrhotic patients,” said Dr. Lawitz. “These findings will inform the design of larger studies aimed at understanding the potential of short-duration triple therapy across multiple patient types.”
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use